Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Nymox reports promising phase II with NX-1207 for BPH

Sep. 21, 2006

Milestone payment to AnorMED for Fosrenol approval in Germany

Sep. 20, 2006

New therapeutic agents for urological disorders imparted in recent patents

Sep. 15, 2006

Pfizer profiles its novel lead 5-HT/NA reuptake inhibitor

Sep. 13, 2006

Italian researchers present a novel selective muscarinic M3 receptor antagonist

Sep. 12, 2006

Enrollment completed in phase II/III study of MN-001 in interstitial cystitis

Sep. 8, 2006

New agents for urinary incontinence disclosed in recent Norgine patent

Sep. 5, 2006

Novel therapeutic agents for nephrotoxicity developed at Hiroshima University

Sep. 4, 2006

New KCa channel activator a promising strategy for micturition control

Sep. 1, 2006

Gabapentin may be effective in treatment of neurogenic overactive bladder

Aug. 30, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...